【生統中心 專題演講】Big Data, Omics, and Precision Medicine
Start Date
2017-12-22 15:00:00
End Date
2017-12-22 17:00:00
Introduction
Big Data, Omics, and Precision Medicine\r\n\r\nThe Holy Grail of precision medicine is the comprehensive integration of patient genotypic with phenotypic data to develop personalized disease prevention and treatment strategies. Next-generation sequencing technologies (NGS) and other types of high-throughput assays have exploded in popularity in recent years, thanks to their ability to produce an enormous volume of data quickly and at relatively low cost compared to more traditional laboratory methods. The ability to generate big data brings us one step closer to the realization of precision medicine; nevertheless, across the life cycle of such data, from experimental design to data capture, management, analysis, and utilization, many challenges remain. In this talk, I will introduce a recent report from the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine, which reviewed the state-of-the-art in biomarker testing for selection of targeted therapies. I will also discuss potential pathways for the seamless integration of cellular and molecular data with clinical, physiological, behavioral, and environmental parameters – a critical next step in advancing the goals of precision medicine, and an enormous opportunity for the data science community to have a tremendous impact on improving patient care and outcomes. \r\n\r\n【主講人】\r\nYu Shyr, Ph.D.\r\nHarold L. Moses Chair in Cancer Research \r\nProfessor and Chair, Department of Biostatistics\r\nDirector, Vanderbilt Center for Quantitative Sciences \r\nDirector, Vanderbilt Technologies for Advanced Genomics Analysis and Research Design \r\nProfessor of Biomedical Informatics, and Health Policy \r\nVanderbilt University Medical Center \r\nNashville, TN, USA \r\n【時間】106/12/22(五)下午15:00-17:00 \r\n【地點】臺北醫學大學大安校區B202會議室\r\n 台北市大安區基隆路二段172-1號B2\r\n\r\n
